Cao D - Search Results

1

Clinical Features Analysis and Survival Nomogram of Primary Small Intestinal Diffuse Large B-Cell Lymphoma.

Liu X, Cao D, Liu H, Ke D, Ke X, Xu X. Liu X, et al. Among authors: cao d. Cancer Manag Res. 2022 Sep 5;14:2639-2648. doi: 10.2147/CMAR.S369086. eCollection 2022. Cancer Manag Res. 2022. PMID: 36090469 Free PMC article.

2

Endostar enhances the antitumor effects of radiation by affecting energy metabolism and alleviating the tumor microenvironment in a Lewis lung carcinoma mouse model.

Zheng YF, Ge W, Xu HL, Cao DD, Liu L, Ming PP, Li CH, Xu XM, Tao WP, Tao ZZ. Zheng YF, et al. Oncol Lett. 2015 Nov;10(5):3067-3072. doi: 10.3892/ol.2015.3679. Epub 2015 Sep 7. Oncol Lett. 2015. PMID: 26722291 Free PMC article.

3

Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis.

Cao DD, Xu HL, Liu L, Zheng YF, Gao SF, Xu XM, Ge W. Cao DD, et al. Oncotarget. 2017 Jul 4;8(27):44976-44993. doi: 10.18632/oncotarget.16689. Oncotarget. 2017. PMID: 28402958 Free PMC article. Review.

4

The extracellular vesicles secreted by lung cancer cells in radiation therapy promote endothelial cell angiogenesis by transferring miR-23a.

Zheng Y, Liu L, Chen C, Ming P, Huang Q, Li C, Cao D, Xu X, Ge W. Zheng Y, et al. Among authors: cao d. PeerJ. 2017 Aug 25;5:e3627. doi: 10.7717/peerj.3627. eCollection 2017. PeerJ. 2017. PMID: 28852584 Free PMC article.

5

The impact of primary tumor location on efficacy of cetuximab in metastatic colorectal cancer patients with different Kras status: a systematic review and meta-analysis.

Cao DD, Xu HL, Xu XM, Ge W. Cao DD, et al. Oncotarget. 2017 Jul 5;8(32):53631-53641. doi: 10.18632/oncotarget.19022. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881837 Free PMC article.

6

Insulin promotes progression of colon cancer by upregulation of ACAT1.

Chen X, Liang H, Song Q, Xu X, Cao D. Chen X, et al. Among authors: cao d. Lipids Health Dis. 2018 May 24;17(1):122. doi: 10.1186/s12944-018-0773-x. Lipids Health Dis. 2018. PMID: 29793481 Free PMC article.

7

A reliable and feasible way to predict the benefits of Nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies.

Cao D, Xu H, Xu X, Guo T, Ge W. Cao D, et al. Oncoimmunology. 2018 Aug 20;7(11):e1507262. doi: 10.1080/2162402X.2018.1507262. eCollection 2018. Oncoimmunology. 2018. PMID: 30377569 Free PMC article.

8

High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients.

Cao D, Xu H, Xu X, Guo T, Ge W. Cao D, et al. Oncoimmunology. 2019 Jun 16;8(9):e1629258. doi: 10.1080/2162402X.2019.1629258. eCollection 2019. Oncoimmunology. 2019. PMID: 31428527 Free PMC article.

9

Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: A meta-analysis.

Cao D, Zheng Y, Xu H, Ge W, Xu X. Cao D, et al. Sci Rep. 2019 Dec 30;9(1):20326. doi: 10.1038/s41598-019-56528-2. Sci Rep. 2019. PMID: 31889159 Free PMC article.

10

The association between antibiotics use and outcome of cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.

Xu H, Xu X, Wang H, Ge W, Cao D. Xu H, et al. Among authors: cao d. Crit Rev Oncol Hematol. 2020 May;149:102909. doi: 10.1016/j.critrevonc.2020.102909. Epub 2020 Feb 19. Crit Rev Oncol Hematol. 2020. PMID: 32146284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,440 results

Search Page

Filters